Skip Navigation

QJM 2005 98(9):706-707; doi:10.1093/qjmed/hci106
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lee, D.K.C.
Right arrow Articles by Currie, G.P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, D.K.C.
Right arrow Articles by Currie, G.P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Correspondence

Safety of beta-blockers in COPD: the jury must still be out

The first 10% of the full text of this article appears below.

Sir,

Egred and colleagues1 encourage the use of beta-blockers in patients with acute coronary syndrome (ACS) and concomitant chronic obstructive pulmonary disease . . . [Full Text of this Article]

D.K.C. Lee, P.S. Borade and G.P. Currie

Department of Respiratory Medicine Ipswich Hospital Ipswich Department of Respiratory Medicine Aberdeen Royal Infirmary Aberdeen email: dkclee@doctors.org.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?